Form 4: Amarin Director Patrice Bonfiglio Reports RSU Vesting

Director Patrice Bonfiglio acquired 838 American Depositary Shares through the vesting of restricted stock units.

Summary

• Director Patrice Bonfiglio exercised and settled 838 restricted stock units (RSUs) on April 18, 2026.
• The transaction involved the vesting of a portion of an RSU grant originally awarded on April 18, 2024.
• The company withheld 403 shares to cover tax liabilities associated with the vesting event.
• Following these transactions, the director holds a total of 836 American Depositary Shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• Director maintains a direct equity stake in the company, aligning interests with shareholders.

Negatives

• The company withheld 403 shares for tax purposes, which is a standard administrative procedure but reduces the net shares received by the director.

Risks

• The filing notes that the company implemented an ADS ratio change on April 11, 2025, where one ADS now represents twenty ordinary shares, which may impact liquidity and trading dynamics.

Future Outlook

The remaining portion of the RSU grant is scheduled to vest on April 18, 2027.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of director equity compensation and does not signal a change in corporate strategy or market outlook.

Comparison to Industry Standards

• The use of RSU vesting and tax withholding is standard practice for executive and director compensation in the pharmaceutical industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Final vesting of the remaining RSU installment scheduled for April 18, 2027.

Key Dates

Keywords

Amarin, AMRN, Form 4, Insider Trading, Equity Compensation, Director Ownership